Table 1.
Demographic and health characteristics of patients
| A-T (n = 42) | Healthy controls (n = 19) | p-value | |
|---|---|---|---|
| Age (years) | 11.6 ± 7.3 | 18.6 ± 4.4 | ≤ 0.01 |
| Sex (f/m) | 23/19 | 9/10 | |
| NfL (pg/mL) | 21.5 ± 3.6 | 9.3 ± 0.49 | ≤ 0.01 |
| SARA (points) | 20.4 ± 8.2 | N/A | |
| IgG substitution | 9/42 | N/A | |
| Granuloma | 5/42 | N/A | |
| History of cancer |
4/42 n = 1 meningioma |
N/A | |
| Peripheral neuropathy | 11/42 | N/A | |
| Dystonia | 3/42 | N/A | |
| Myoclonus | 12/42 | N/A | |
| Wheelchair-bound | 18/42 | N/A | |
| IgA deficiency | 32/42 | N/A | |
| Hepatopathy | 12/42 | N/A | |
| Diabetes | 4/42 | N/A |
Values are shown as mean ± SD. SARA scores were available from 28 patients